Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration

Journal of Alzheimer's Disease

Volumn 45, Issue 2, 2015, Pages 349-362

  Friedland, Robert P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Alzheimer's disease; amyloid; bacterial amyloid; metagenome; microbiota; neurodegenerative diseases; neuroinflammation; oxidative stress; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AQUAPORIN; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; CYTOKINE;

ALZHEIMER DISEASE; GENETIC CONSERVATION; HUMAN; INNATE IMMUNITY; MICROFLORA; MOLECULAR MIMICRY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; POTYVIRUS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEOMICS; REVIEW; TOBACCO MOSAIC VIRUS; ANIMAL; DEGENERATIVE DISEASE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CYTOKINES; HUMANS; MICROBIOTA; MOLECULAR MIMICRY; NEURODEGENERATIVE DISEASES;

EID: 84925348854     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142841     Document Type: Review

References (124)

1. Bates HW (1861) Contributions to an insect fauna of the Amazon valley. Lepidoptera: Heliconidae. Trans Linnean Soc London 23, 495-566.
2. Damian RT (1997) Parasite immune evasion and exploitation: Reflections and projections. Parasitology 115(Suppl), S169-S175.
3. Lousberg EL, Diener KR, Brown MP, Hayball JD (2011) Innate immune recognition of poxviral vaccine vectors. Expert Rev Vaccines 10, 1435-1449.
4. Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, Perry G, Zagorski MG (2008) Antibodies to potato virus Y bind the amyloid beta peptide: Immunohistochemical and NMR studies. J Biol Chem 283, 22550-22556.
5. Liu R, Vaishnav RA, Roberts AM, Friedland RP (2013) Humans have antibodies against a plant virus: Evidence from tobacco mosaic virus. PLoS One 8, e60621.
6. Liu R, Vaishnav RA, Roberts AM, Friedland RP (2014) Parkinson disease, edible Solanaceae, and tobacco mosaic virus. Ann Neurol 75, 162-163.
7. Vaishnav RA, Liu R, Chapman J, Roberts AM, Ye H, Rebolledo-Mendez JD, Tabira T, Fitzpatrick AH, Achiron A, Running MP, Friedland RP (2013) Aquaporin 4 molecular mimicry and implications for neuromyelitis optica. J Neuroimmunol 260, 92-98.
8. Rebolledo-Mendez JD, Vaishnav RA, Cooper NG, Friedland RP (2013) Cross-kingdom sequence similarities between human micro-RNAs and plant viruses. Commun Integr Biol 6, e24951.
9. Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39, 31-39.
10. Oldstone MB (2014) Molecular mimicry: Its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclon Antib Immunodiagn Immunother 33, 158-165.
11. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
12. Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA (2008) Antigen-antibody dissociation in Alzheimer disease: A novel approach to diagnosis. J Neurochem 106, 1350-1356.
13. Nishiyama Y, Taguchi H, Hara M, Planque SA, Mitsuda Y, Paul S (2014) Metal-dependent amyloid beta-degrading catalytic antibody construct. J Biotechnol 180, 17-22.
14. Colson P, Richet H, Desnues C, Balique F, Moal V, Grob JJ, Berbis P, Lecoq H, Harle JR, Berland Y, Raoult D (2010) Pepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humans. PLoS One 5, e10041.
15. Colussi TM, Costantino DA, Hammond JA, Ruehle GM, Nix JC, Kieft JS (2014) The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA. Nature 511, 366-369.
16. Reijerkerk A, Lopez-Ramirez MA,van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, Vos JB, van der Pouw Kraan TC, van Zonneveld AJ, Horrevoets AJ, Prat A, Romero IA, de Vries HE (2013) MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: Implications for multiple sclerosis. J Neurosci 33, 6857-6863.
17. Cazalla D, Yario T, Steitz JA (2010) Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563-1566.
18. Libri V, Helwak A, Miesen P, Santhakumar D, Borger JG, Kudla G, Grey F, Tollervey D, Buck AH (2012) Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc Natl Acad Sci U S A 109, 279-284.
19. Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, Li J, Bian Z, Liang X, Cai X, Yin Y, Wang C, Zhang T, Zhu D, Zhang D, Xu J, Chen Q, Ba Y, Liu J, Wang Q, Chen J, Wang J, Wang M, Zhang Q, Zhang J, Zen K, Zhang CY (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res 22, 107-126.
20. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106, 13010-13015.
21. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136, 1128-1138.
22. Guo JL, Lee VM (2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286, 15317-15331.
23. Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51.
24. Braak H, Del Tredici K (2008) Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916-1925.
25. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197-211.
26. Shults CW (2006) Lewy bodies. Proc Natl Acad Sci U S A 103, 1661-1668.
27. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J (2010) Prion-like disorders: Blurring the divide between transmissibility and infectivity. J Cell Sci 123, 1191-1201.
28. Walker LC, Jucker M (2011) Amyloid by default. Nat Neurosci 14, 669-670.
29. Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, Parhizkar S, Ward MA, Cavallini A, Jackson S, Bose S, Clavaguera F, Tolnay M, Lavenir I, Goedert M, Hutton ML, O'Neill MJ (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: The pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127, 667-683.
30. Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lorincz P, Perju-Dumbrava L, Giera R, Pirker W, Lutz M, Lachmann I, Budka H, Uversky VN, Molnar K, Laszlo L (2014) Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 69C, 76-92.
31. Song HL, Shim S, Kim DH, Won SH, Joo S, Kim S, Jeon NL, Yoon SY (2014) beta-Amyloid is transmitted via neuronal connections along axonal membranes. Ann Neurol 75, 88-97.
32. Prusiner SB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513.
33. van Keulen LJ, Vromans ME, van Zijderveld FG (2002) Early and late pathogenesis of natural scrapie infection in sheep. APMIS 110, 23-32.
34. Attems J, Walker L, Jellinger KA (2014) Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 127, 459-475.
35. Haehner A, Hummel T, Reichmann H (2011) Olfactory loss in Parkinson's disease. Parkinsons Dis 2011, 450939.
36. Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2014) alpha-Synuclein in the olfactory system in Parkinson's disease: Role of neural connections on spreading pathology. Brain Struct Funct 219, 1513-1526.
37. Hawkes CH, Del Tredici K, Braak H (2009) Parkinson's disease: The dual hit theory revisited. Ann N Y Acad Sci 1170, 615-622.
38. Orru CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, Fiorini M, Pocchiari M, Monaco S, Caughey B, Zanusso G (2014) A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med 371, 519-529.
39. Human Microbiome Project, Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
40. Gordon JI (2012) Honor thy gut symbionts redux. Science 336, 1251-1253.
41. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336, 1262-1267.
42. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH (2013) The influence of diet on the gut microbiota. Pharmacol Res 69, 52-60.
43. Heintz C, Mair W (2014) You are what you host: Microbiome modulation of the aging process. Cell 156, 408-411.
44. Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336, 1268-1273.
45. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M, Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O'Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184.
46. Hufnagel DA, Tukel C, Chapman MR (2013) Disease to dirt: The biology of microbial amyloids. PLoS Pathog 9, e1003740.
47. Schwartz K, Boles BR (2013) Microbial amyloids- functions and interactions within the host. Curr Opin Microbiol 16, 93-99.
48. Oli MW, Otoo HN, Crowley PJ, Heim KP, Nascimento MM, Ramsook CB, Lipke PN, Brady LJ (2012) Functional amyloid formation by Streptococcus mutans. Microbiology 158, 2903-2916.
49. Bednarska NG, Schymkowitz J, Rousseau F, Van Eldere J (2013) Protein aggregation in bacteria: The thin boundary between functionality and toxicity. Microbiology 159, 1795-1806.
50. Soto C (2012) Transmissible proteins: Expanding the prion heresy. Cell 149, 968-977.
51. Pavlopoulos E, Trifilieff P, Chevaleyre V, Fioriti L, Zairis S, Pagano A, Malleret G, Kandel ER (2011) Neuralized1 activates CPEB3: A function for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell 147, 1369-1383.
52. Bokranz W, Wang X, Tschape H, Romling U (2005) Expression of cellulose and curli fimbriae by Escherichia coli isolated from the gastrointestinal tract. J Med Microbiol 54, 1171-1182.
53. Cherny I, Rockah L, Levy-Nissenbaum O, Gophna U, Ron EZ, Gazit E (2005) The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats. J Mol Biol 352, 245-252.
54. Bhattacharjee S, Lukiw WJ (2013) Alzheimer's disease and the microbiome. Front Cell Neurosci 7, 153.
55. Nakano K, Hokamura K, Taniguchi N, Wada K, Kudo C, Nomura R, Kojima A, Naka S, Muranaka Y, Thura M, Nakajima A, Masuda K, Nakagawa I, Speziale P, Shimada N, Amano A, Kamisaki Y, Tanaka T, Umemura K, Ooshima T (2011) The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun 2, 485.
56. Solomon A, Richey T, Murphy CL, Weiss DT, Wall JS, Westermark GT, Westermark P (2007) Amyloidogenic potential of foie gras. Proc Natl Acad Sci U S A 104, 10998-11001.
57. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M, Higuchi K (2001) Transmission of mouse senile amyloidosis. Lab Invest 81, 493-499.
58. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A (2013) Microfold (M) cells: Important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol 6, 666-677.
59. O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7, 688-693.
60. Kujala P, Raymond CR, Romeijn M, Godsave SF, van Kasteren SI, Wille H, Prusiner SB, Mabbott NA, Peters PJ (2011) Prion uptake in the gut: Identification of the first uptake and replication sites. PLoS Pathog 7, e1002449.
61. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25, 419-429.
62. Leung JY, Chapman JA, Harris JA, Hale D, Chung RS, West AK, Chuah MI (2008) Olfactory ensheathing cells are attracted to, and can endocytose, bacteria. Cell Mol Life Sci 65, 2732-2739.
63. Panni P, Ferguson IA, Beacham I, Mackay-Sim A, Ekberg JA, St John JA (2013) Phagocytosis of bacteria by olfactory ensheathing cells and Schwann cells. Neurosci Lett 539, 65-70.
64. Hartman K, Brender JR, Monde K, Ono A, Evans ML, Popovych N, Chapman MR, Ramamoorthy A (2013) Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: Cross-seeding of dissimilar amyloid sequences. PeerJ 1, e5.
65. Morales R, Estrada LD, Diaz-Espinoza R, Morales- Scheihing D, Jara MC, Castilla J, Soto C (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30, 4528-4535.
66. Tanaka M, Chien P, Yonekura K, Weissman JS (2005) Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121, 49-62.
67. Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R (2009) Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A 106, 7443-7448.
68. Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB (2014) Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc Natl Acad Sci U S A 111, 10323-10328.
69. Glabe CG (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29, 542-547.
70. Kayed R, Glabe CG (2006) Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol 413, 326-344.
71. Cui D, Kawano H, Hoshii Y, Liu Y, Ishihara T (2008) Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates. Amyloid 15, 77-83.
72. Miglio A, Moscati L, Fruganti G, Pela M, Scoccia E, Valiani A, Maresca C (2013) Use of milk amyloid A in the diagnosis of subclinical mastitis in dairy ewes. J Dairy Res 80, 496-502.
73. Villar-Pique A, Sabate R, Lopera O, Gibert J, Torne JM, Santos M, Ventura S (2010) Amyloid-like protein inclusions in tobacco transgenic plants. PLoS One 5, e13625.
74. Lavelle EC, Murphy C, O'Neill LA, Creagh EM (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3, 17-28.
75. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236.
76. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, Peterson DA, Stappenbeck TS, Hsieh CS (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250-254.
77. Li J, Lee DS, Madrenas J (2013) Evolving bacterial envelopes and plasticity of TLR2-dependent responses: Basic research and translational opportunities. Front Immunol 4, 347.
78. Nishimori JH, Newman TN, Oppong GO, Rapsinski GJ, Yen JH, Biesecker SG, Wilson RP, Butler BP, Winter MG, Tsolis RM, Ganea D, Tukel C (2012) Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa. Infect Immun 80, 4398-4408.
79. Tukel C, Nishimori JH, Wilson RP, Winter MG, Keestra AM, van Putten JP, Baumler AJ (2010) Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms. Cell Microbiol 12, 1495-1505.
80. Czirr E, Wyss-Coray T (2012) The immunology of neurodegeneration. J Clin Invest 122, 1156-1163.
81. Bechmann I, Priller J, Kovac A, Bontert M, Wehner T, Klett FF, Bohsung J, Stuschke M, Dirnagl U, Nitsch R (2001) Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci 14, 1651-1658.
82. Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A, Alberoni M, Nemni R, Clerici M (2014) A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. J Alzheimers Dis 38, 403-413.
83. Trudler D, Farfara D, Frenkel D (2010) Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: Towards future therapeutic application. Mediators Inflamm 2010, pii: 497987.
84. Palaga T, Buranaruk C, Rengpipat S, Fauq AH, Golde TE, Kaufmann SH, Osborne BA (2008) Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur J Immunol 38, 174-183.
85. McGeer PL, McGeer EG (2002) Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol 8, 529-538.
86. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
87. Beraud D, Maguire-Zeiss KA (2012) Misfolded alpha-synuclein and Toll-like receptors: Therapeutic targets for Parkinson's disease. Parkinsonism Relat Disord 18(Suppl 1), S17-S20.
88. Richard KL, Filali M, Prefontaine P, Rivest S (2008) Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 28, 5784-5793.
89. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA (2014) NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045-1059.
90. Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, Jones SA, Brennan P, Topley N, Labeta MO (2009) Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol 183, 506-517.
91. Rapsinski GJ, Newman TN, Oppong GO, van Putten JP, Tukel C (2013) CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J Biol Chem 288, 14178-14188.
92. Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10, 217-224.
93. Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R, Kaoma T, Muller A, Vallar L, Di Monte DA, Balling R, Neumann H (2014) Neurodegeneration by activation of the microglial complement-phagosome pathway. J Neurosci 34, 8546-8556.
94. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, et al. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1, 693-699.
95. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
96. Rashid T, Wilson C, Ebringer A (2013) The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption. Clin Dev Immunol 2013, 872632.
97. Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC, Gibbs JR, Bras J, Sassi C, Harari O, Bertelsen S, Lupton MK, Powell J, Bellenguez C, Brown K, Medway C, Haddick PC, van der Brug MP, Bhangale T, Ortmann W, Behrens T, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Haines JL, Turton J, Braae A, Barber I, Fagan AM, Holtzman DM, Morris JC, Williams J, Kauwe JS, Amouyel P, Morgan K, Singleton A, Hardy J, Goate AM, Cruchaga C (2014) Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol Aging 35, 1510 e1519-1526.
98. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL, 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Younkin SG, Petersen RC, Ertekin-Taner N, Uitti RJ, Meschia JF, Boylan KB, Boeve BF, Graff-Radford NR, Wszolek ZK, Dickson DW, Rademakers R, Ross OA (2013) TREM2 in neurodegeneration: Evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener 8, 19.
99. Verbrugghe P, Kujala P, Waelput W, Peters PJ, Cuvelier CA (2008) Clusterin in human gut-associated lymphoid tissue, tonsils, and adenoids: Localization to M cells and follicular dendritic cells. Histochem Cell Biol 129, 311-320.
100. Carare RO, Teeling JL, Hawkes CA, Puntener U, Weller RO, Nicoll JA, Perry VH (2013) Immune complex formation impairs the elimination of solutes from the brain: Implications for immunotherapy in Alzheimer's disease. Acta Neuropathol Commun 1, 48.
101. Hawkes CA, Carare RO, Weller RO (2014) Amyloid and tau in the brain in sporadic Alzheimer's disease: Defining the chicken and the egg. Acta Neuropathol 127, 617-618.
102. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C (2009) Age, neuropathology, and dementia. N Engl J Med 360, 2302-2309.
103. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39, 51-68.
104. McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: Implications for therapy. Acta Neuropathol 126, 479-497.
105. Bernstein KE, Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Lopes DH, Shah KH, Bernstein EA, Fuchs DT, Yu JJ, Pham M, Black KL, Shen XZ, Fuchs S, Koronyo-Hamaoui M (2014) Angiotensin-converting enzyme over-expression in myelomonocytes prevents Alzheimer's-like cognitive decline. J Clin Invest 124, 1000-1012.
106. Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA (2008) Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 28, 6333-6341.
107. Monsonego A, Imitola J, Petrovic S, Zota V, Nemirovsky A, Baron R, Fisher Y, Owens T, Weiner HL (2006) Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5048-5053.
108. Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, Schwartz M (2006) Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A 103, 11784-11789.
109. Aguzzi A (2014) Neurodegeneration: Alzheimer's disease under strain. Nature 512, 32-34.
110. Bagriantsev S, Liebman S (2006) Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system. BMC Biol 4, 32.
111. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70, 223-228.
112. Fischer S, Dolu MH, Zundt B, Meyer G, Geisler S, Jungst D (2001) Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest 31, 789-795.
113. Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat Rev Neurol 9, 106-118.
114. Urosevic N, Martins RN (2008) Infection and Alzheimer's disease: The APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13, 421-435.
115. Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D (2013) Inflammatory components in human Alzheimer's disease and after active amyloid-beta42 immunization. Brain 136, 2677-2696.
116. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20, 415-418.
117. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P, World Federation of Neurology Dementia Research G (2008) Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol 7, 812-826.
118. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139.
119. Satoh M, Ishikawa Y, Minami Y, Takahashi Y, Nakamura M (2008) Role of Toll like receptor signaling pathway in ischemic coronary artery disease. Front Biosci 13, 6708-6715.
120. Kalaria RN, Ihara M (2013) Dementia: Vascular and neurodegenerative pathways-will they meet? Nat Rev Neurol 9, 487-488.
121. Tang Q, Roan NR, Yamamura Y (2013) Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture. J Virol 87, 12583-12591.
122. Usmani SM, Zirafi O, Muller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarstrom P, Wetzel R, Pilcher CD, Gagsteiger F, Fandrich M, Kirchhoff F, Munch J (2014) Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nat Commun 5, 3508.
123. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014) Microbiota and neurodevelopmental windows: Implications for brain disorders. Trends Mol Med 20, 509-518.
124. Lloyd SJ, Ritchie JM, Torres AG (2012) Fimbriation and curliation in Escherichia coli O157:H7: A paradigm of intestinal and environmental colonization. Gut Microbes 3, 272-276.